PROCEPT BioRobotics Corporation PRCT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.96% | 19.34% | 20.20% | 11.94% | 42.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.96% | 19.34% | 20.20% | 11.94% | 42.76% |
| Cost of Revenue | 13.04% | 27.64% | 16.74% | 22.41% | 36.64% |
| Gross Profit | 20.63% | 14.94% | 22.16% | 6.05% | 46.31% |
| SG&A Expenses | 22.88% | 23.74% | 17.92% | 20.66% | 38.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.98% | 23.10% | 19.81% | 22.15% | 31.84% |
| Operating Income | -18.04% | -36.51% | -18.84% | -57.49% | -3.41% |
| Income Before Tax | -24.31% | -37.68% | -27.83% | -60.40% | -1.92% |
| Income Tax Expenses | -270.59% | -30.88% | 8.51% | -48.37% | -- |
| Earnings from Continuing Operations | -23.84% | -37.20% | -27.90% | -58.28% | -2.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.84% | -37.20% | -27.90% | -58.28% | -2.08% |
| EBIT | -18.04% | -36.51% | -18.84% | -57.49% | -3.41% |
| EBITDA | -15.12% | -37.38% | -18.90% | -60.66% | -2.25% |
| EPS Basic | -20.38% | -33.31% | -24.31% | -52.00% | 4.74% |
| Normalized Basic EPS | -20.81% | -48.22% | -24.21% | -54.05% | 4.84% |
| EPS Diluted | -20.38% | -33.31% | -24.31% | -52.00% | 4.74% |
| Normalized Diluted EPS | -20.81% | -48.22% | -24.21% | -54.05% | 4.84% |
| Average Basic Shares Outstanding | 2.87% | 2.93% | 2.90% | 4.15% | 7.14% |
| Average Diluted Shares Outstanding | 2.87% | 2.93% | 2.90% | 4.15% | 7.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |